Apart from being used in the classification of GBM subtypes, CD133, DLX2, and Nestin have additionally been applied in the characterization of glioma cells with similarities to neural stem cells, which are referred to as, e.g., BCPCs, CSCs, GSCs, or SLGCs [12, 16, 22–25]. Here, DLX2 is linked to glioblastoma.